Quest Diagnostics Inc.

Organisation

500 Plaza Drive, Secaucus, NJ, United States, 07094

Headquarters

46000

Employees

Health Services

Industry

Stephen Rusckowski

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Price

Target

Quest Diagnostics Inc. (DGX) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Quest Diagnostics Inc. (DGX) share price will touch around $218.5 in next 12-months.

Currently 22 wall-street analysts regularly analyze the financials of Quest Diagnostics Inc. on a frequent basis to provide recommendations along with target share price. 22 analysts offering 12-month price forecasts for Quest Diagnostics Inc. (DGX) have a share price target of $218.5. This median of share price forecast represents a 9.99% upside from the latest price of $198.66 as on 18.03.26.

Quest Diagnostics Inc. (DGX) Share Price Forecast

Home

US Stocks

Quest Diagnostics Inc. (DGX)

Quest Diagnostics Inc. Stock Forecast

Quest Diagnostics Inc. Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Quest Diagnostics Inc. (DGX): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Quest Diagnostics Inc.'s share price and its median forecast price. As on 18.03.26, the difference is -7.22%

Quest Diagnostics Inc. Forecast and Target Price

Quest Diagnostics Inc. (DGX) Share Price Forecast

Quest Diagnostics Inc. (DGX) Price vs Consensus Price Target

Quest Diagnostics Inc. (DGX) Share Price Forecast v/s Share Price Today

Quest Diagnostics Inc. (DGX): Difference between Current Price & Median Forecasted Price

Quest Diagnostics Inc. (DGX) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price